| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.7M | -36.4% | -55.6% |
| Gross Profit | -$6.8M | +22.1% | -1883.6% |
| R&D Expense | $855K | -8.4% | -12.8% |
| SG&A Expense | $2.0M | -8.0% | -10.5% |
| Operating Income | -$9.7M | +18.4% | -237.1% |
| Pre-tax Income | -$9.4M | +9.9% | -680.8% |
| Income Tax | -$27K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $85.6M | -10.1% | -35.9% |
| Accounts Receivable | $7.9M | -28.1% | -50.7% |
| Inventory | $6.1M | -36.2% | -75.3% |
| Current Assets | $112.8M | -12.4% | -36.0% |
| Total Assets | $203.5M | -6.7% | -20.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | — |
| Capital Expenditures | $14.8M | — | — |
| Investing Cash Flow | -$14.4M | — | — |
| Financing Cash Flow | -$8.3M | — | — |
| Free Cash Flow | -$16.1M | — | — |
| -177.1% |
| -800.0% |
| Net Income | -$9.3M | +10.5% | -680.5% |
| EPS (Basic) | -$0.21 | +12.5% | -600.0% |
| EPS (Diluted) | -$0.21 | +12.5% | -600.0% |
| $25.3M |
| -18.2% |
| -14.6% |
| Total Liabilities | $34.4M | -14.1% | -20.4% |
| Stockholders' Equity | $169.1M | -5.1% | -20.7% |